TL;DR
A thorough analysis of the impact of neoadjuvant chemotherapy on the tumor immune microenvironment (TIME) in gynaecological tumors provides a solid foundation for the development of late-stage immunotherapy and highlights the importance of therapeutic strategies targeting immune cells in TIME in anti-tumor therapy.
AI-generated by Semantic Scholar
